Hassan H, Greve B, Pavao MS, Kiesel L, Ibrahim SA, Götte M
Forschungsartikel (Zeitschrift)Syndecan-1 is a cell surface heparan sulfate proteoglycan with various biological functions relevant to tumor progression and inflammation, including cell-cell adhesion, cell-matrix interaction, and cytokine signaling driving cell proliferation and motility. Syndecan-1 is a prognostic factor in breast cancer, and has a predicitive value for neodadjuvant chemotherapy. It is still poorly understood how syndecan-1 integrates matrix-dependent and cytokine-dependent signaling processes in the tumor microenvironment. Here, we evaluated the potential role of syndecan-1 in modulating matrix-dependent breast cancer cell migration in the presence of interleukin-6, and its potential involvement in resistance to irradiation in vitro. MDA-MB-231 breast cancer cells were transiently transfected with syndecan-1 small interfering RNA or control reagents, and this was followed by stimulation with interleukin-6 or irradiation. Cellular responses were monitored by adhesion, migration and colony formation assays, as well as analysis of cell signaling. Syndecan-1 depletion increased cell adhesion to fibronectin. Increased migration on fibronectin was significantly suppressed by interleukin-6, and GRGDSP peptides inhibited both adhesion and migration. Interleukin-6-induced activation of focal adhesion kinase and reduction of constitutive nuclear factor kappaB signaling were decreased in syndecan-1-deficient cells. Focal adhesion kinase hyperactivation in syndecan-1-depleted cells was associated with dramatically reduced radiation sensitivity. We conclude that loss of syndecan-1 leads to enhanced activation of ?1 -integrins and focal adhesion kinase, thus increasing breast cancer cell adhesion, migration, and resistance to irradiation. Syndecan-1 deficiency also attenuates the modulatory effect of the inflammatory microenvironment constituent interleukin-6 on cancer cell migration.
| Götte, Martin | Klinik für Frauenheilkunde und Geburtshilfe |
| Kiesel, Ludwig | Klinik für Frauenheilkunde und Geburtshilfe |
Laufzeit: 01.03.2013 - 31.12.2013 | 1. Förderperiode Gefördert durch: Deutscher Akademischer Austauschdienst Art des Projekts: Beteiligung in sonstigen Verbundvorhaben |
| Dual roles of the heparan sulphate proteoglycan Syndecan-1 in cytokine- and integrin-mediated modulation of breast cancer stem cell function and motility Promovend*in: Hassan, Hebatallah Eshmawy Mohamed Mahgoub | Betreuer*innen: Götte, Martin; Liebau, Eva; Greve, Burkhard Zeitraum: 07.12.2009 - 11.01.2013 Promotionsverfahren erfolgt(e) an: Promotionsverfahren an der Universität Münster | |
| Functional analysis of Syndecan-1, a novel target of miR-10b, in breast cancer progression Promovend*in: Abdel-Aziz Ibrahim, Sherif | Betreuer*innen: Götte, Martin; Liebau, Eva; Greve, Burkhard Zeitraum: 05.01.2008 - 19.07.2011 Promotionsverfahren erfolgt(e) an: Promotionsverfahren an der Universität Münster |